Skip to main
CTRE

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

CareTrust REIT is viewed positively because it is aggressively deploying capital into healthcare real estate at accretive returns, including the $764 million acquisition on October 1 and another $669 million expected throughout 2027 in the LNT transaction. The staggered UK care home portfolio offers a low-5.0% cash yield during lease-up, rising to a mid-/high-6.0% yield in year 1 of operations, while management’s broader activity includes $1.4 billion of deals YTD and a $540 million pipeline. With tenant credit concerns stabilizing, stronger SNF fundamentals, and estimated core earnings growth of 17.7% in 2026, 9.8% in 2027, and 6.4% in 2028, the stock appears positioned for continued NAV and AFFO expansion.

Bears say

CareTrust REIT is viewed negatively because its earnings trajectory depends heavily on a fragile skilled nursing reimbursement environment, where Medicaid cuts could tighten operator economics and stall growth at its 2026 run-rate. The outlook is further clouded by unpredictable SNF regulation, potential headline risk tied to PACS and the still-unresolved DOJ investigation, and the possibility that intensified competition will make future acquisitions harder and more costly. With valuation vulnerable to a pullback toward the 7-year historical average multiple of about 14.0x, the stock faces downside if cost of capital rises or operator labor pressures weaken tenant stability.

CareTrust REIT (CTRE) has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 10 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of Oct 10, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $43.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $43.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.